Microbial induction of CARD15 expression in intestinal epithelial cells via toll-like receptor 5 triggers an antibacterial response loop

Journal of Cellular Physiology

Volumn 209, Issue 2, 2006, Pages 241-252

  Begue, B ^a,b   Dumant, C ^a,b   Bambou, J C ^a,b   Beaulieu, J F ^c   Chamaillard, M ^a   Hugot, J P ^d   Goulet, O ^a,b,e   Schmitz, J ^a,b,e   Philpott, D J ^f   Cerf Bensussan, N ^a,b,e   Ruemmele, F M ^a,b,e,g  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

^d HÔPITAL ROBERT DEBRÉ   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f INSTITUT PASTEUR   (France)

^g Hôpital Necker Enfants Malades ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CHEMOKINE; CHEMOKINE CCL20; FLAGELLIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MURAMYL DIPEPTIDE; MUTANT PROTEIN; PEPTIDE; PLASMID DNA; RECOMBINANT PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ARTICLE; BACTERIAL IMMUNITY; BACTERIUM CONTAMINATION; BACTERIUM MUTANT; CELL CONTACT; COMMENSAL ESCHERICHIA COLI; CONTROLLED STUDY; CROHN DISEASE; ESCHERICHIA COLI K 12; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; ILEUM; IMMUNE DEFICIENCY; IN VITRO STUDY; INFLAMMATION; INNATE IMMUNITY; INTESTINE EPITHELIUM CELL; KNOCKOUT GENE; NONHUMAN; PLASMA CLEARANCE; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN SYNTHESIS REGULATION;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; AMINO ACID MOTIFS; ANTIMICROBIAL CATIONIC PEPTIDES; CACO-2 CELLS; CELLS, CULTURED; ENTEROCYTES; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; HT29 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUTANT PROTEINS; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; RNA, MESSENGER; TOLL-LIKE RECEPTOR 5;

BACTERIA (MICROORGANISMS);

EID: 33749266363     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20739     Document Type: Article

References (39)

1. Andersen-Nissen E, Smith KD, Strobe KL, Barrett SL, Cookson BT, Logan SM, Aderem A. 2005. Evasion of Toll-like receptor 5 by flagellated bacteria. Proc Natl Acad Sci USA 102:9247-9252.
2. Ayabe T, Satchell DP, Wilson CL, Parks WC, Selsted ME, Ouellette AJ. 2000. Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol 1(1):113-118.
3. Bambou JC, Giraud A, Menard S, Begue B, Rakotobe S, Heyman M, Taddei F, Cerf-Bensussan N, Gaboriau-Routhiau V. 2004. In vitro and ex vivo activation of the TLR5 signaling pathway in intestinal epithelial cells by a commensal Escherichia coli strain. J Biol Chem 279:42984-42992.
4. Berrebi D, Maudinas R, Hugot JP, Chamaillard M, Chareyre F, De Lagausie P, Yang C, Desreumaux P, Giovannini M, Cezard JP, Zouali H, Emilie D, Peuchmaur M. 2003. Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon. Gut 52:840-846.
5. Blattner FR, Plunkett G III, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y. 1997. The complete genome sequence of Escherichia coli K-12. Science 277:1453-1474.
6. Bouma G, Strober W. 2003. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3:521-533.
7. Cellier C, Patey N, Mauvieux L, Jabri B, Delabesse E, Cervoni JP, Burtin ML, Guy-Grand D, Bouhnik Y, Modigliani R, Barbier JP, Macintyre E, Brousse N, Cerf-Bensussan N. 1998. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology 114:471-841.
8. Chamaillard M, Philpott D, Girardin SE, Zouali H, Lesage S, Chareyre F, Bui TH, Giovannini M, Zaehringer U, Penard-Lacronique V, Sansonetti PJ, Hugot JP, Thomas G. 2003. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci USA 100:3455-3460.
9. Cunliffe RN, Mahida YR. 2004. Expression and regulation of antimicrobial peptides in the gastrointestinal tract. J Leukoc Biol 75:49-58.
10. Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di Martino P, Desreumaux P, Gambiez L, Joly B, Cortot A, Colombel JF. 1998. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 117:1089-1097.
11. Eckmann L, Karin M. 2005. NOD2 and Crohn's disease: Loss or gain of function? Immunity 22:661-667.
12. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, Philpott DJ, Sansonetti PJ. 2003. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 278:8869-8872.
13. Gutierrez O, Pipaon C, Inohara N, Fontalba A, Ogura Y, Prosper F, Nunez G, Fernandez-Luna JL. 2002. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J Biol Chem 277:41701-41705.
14. Harton JA, Linhoff MW, Zhang J, Ting JP. 2002. Cutting edge: CATERPILLER: A large family of mammalian genes containing CARD, pyrin, nucleotide-binding, and leucine-rich repeat domains. J Immunol 169:4088-4093.
15. Hisamatsu T, Suzuki M, Reinecker HC, Nadeau WJ, McCormick BA, Podolsky DK. 2003. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 124:993-1000.
16. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche V, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Housseau C, Macry J, Colombei JF, Sahbatou M, Thomas G. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411:599-603.
17. Iimura M, Gallo RL, Hase K, Miyamoto Y, Eckmann L, Kagnoff MF. 2005. Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J Immunol 174:4901-4907.
18. Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, Crespo J, Fukase K, Inamura S, Kusumoto S, Hashimoto M, Foster SJ, Moran AP, Fernandez-Luna JL, Nunez G. 2003. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 278:5509-5512.
19. Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, Nunez G, Flavell RA. 2005. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307:731-734.
20. Lala S, Ogura Y, Osborne C, Hor SY, Bromfield A, Davies S, Ogunbiyi O, Nunez G, Keshav S. 2003. Crohn's disease and the NOD2 gene: A role for paneth cells. Gastroenterology 125:47-57.
21. Lodes MJ, Cong Y, Elson CO, Mohamath R, Landers CJ, Targan SR, Fort M, Hershberg RM. 2004. Bacterial flagellin is a dominant antigen in Crohn's diseae. J Clin Invest 113:1296-1306.
22. Maeda S, Hsu LC, Liu H, Bankston LA, Iimura M, Kagnoff MF, Eckmann L, Karin M. 2005. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 307:734-738.
23. Nuding S, Fellermann K, Wehkamp J, Mueller HA, Stange EF. 2005. A flow cytometric assay to monitor antimicrobial activity of defensins and cationic tissue extracts. J Microbiol Methods 2006 May; 65(2):335-345. Epub 2005 Sep 22.
24. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayiess TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH. 2001a. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411:603-606.
25. Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G. 2001b. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 276:4812-4818.
26. Otte JM, Cario E, Podolsky DK. 2004. Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 126:1054-1070.
27. Perez-Canadillas JM, Zaballos A, Gutierrez J, Varona R, Roncal F, Albar JP, Marquez G, Bruix M. 2001. NMR solution structure of murine CCL20/MIP-Salpha, a chemokine that specifically chemoattracts immature dendritic cells and lymphocytes through its highly specific interaction with the beta-chemokine receptor CCR6. J Biol Chem 276:28372-28379.
28. Philpott DJ, Yamaoka S, Israel A, Sansonetti PJ. 2000. Invasive Shigella flexneri activates NF-kappa B through a lipopolysaccharide-dependent innate intracellular response and leads to IL-8 expression in epithelial cells. J Immunol 165:903-914.
29. Podolsky DK. 2002. Inflammatory bowel disease. N Engl J Med 347:417-429.
30. Rosenstiel P, Fantini M, Brautigam K, Kuhbacher T, Waetzig GH, Seegert D, Schreiber S. 2003. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 124:1001-1009.
31. Ruemmele FM, Beaulieu JF, Dionne S, Levy E, Seidman EG, Cerf-Bensussan N, Lentze MJ. 2002. Lipopolysaccharide modulation of normal enterocyte turnover by toll-like receptors is mediated by endogenously produced tumour necrosis factor alpha. Gut 51:842-848.
32. Starner TD, Barker CK, Jia HP, Kang J, McCray PB Jr. 2003. CCL20 is an inducible product of human airway epithelia with innate immune properties. Am J Respir Cell Mol Biol 29:627-633.
33. Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke V, Ortner M, Weber J, Hoffmann U, Schreiber S, Dietel M, Lochs H. 2002. Mucosal flora in inflammatory bowel disease. Gastroenterology 122:44-54.
34. Targan SR, Landers CJ, Yang H, Lodes MJ, Cong Y, Papadakis KA, Vasiliauskas E, Elson CO, Hershberg RM. 2005. Gastroenterology 2005 Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology 128:2020-2028.
35. van der Waaij LA, Harmsen HJ, Madjipour M, Kroese FG, Zwiers M, van Dullemen HM, de Boer NK, Welling GW, Jansen PL. 2005. Bacterial population analysis of human colon and terminal ileum biopsies with 16S rRNA-based fluorescent probes: Commensal bacteria live in suspension and have no direct contact with epithelial cells. Inflamm Bowel Dis 11:865-871.
36. Vavricka SR, Musch MW, Chang JE, Nakagawa Y, Phanvijhitsiri K, Waypa TS, Merlin D, Schneewind O, Chang EB. 2004. hPepT1 transports muramyl dipeptide, activating NF-kappaB and stimulating IL-8 secretion in human colonie Caco2/bbe cells. Gastroenterology 127:1401-1409.
37. Watanabe T, Kitani A, Murray PJ, Strober W. 2004. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 5:800-808.
38. Wehkamp J, Harder J, Weichenthal M, Schwab M, Schaffeler E, Schlee M, Herrlinger KR, Stallmach A, Noack F, Fritz P, Schroder JM, Bevins CL, Fellermann K, Stange EF. 2004. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 53:1658-1664.
39. Wilson CL, Ouellette AJ, Satchell DP, Ayabe T, Lopez-Boado YS, Stratman JL, Hultgren SJ, Matrisian LM, Parks WC. 1999. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 286:113-117.